5 amino 1mq 50 mg 5-amino-1mq (50mg) 5-amino-1MQ 50 mg –

In a randomized, double-blind, placebo-controlled trial published in The Lancet, obese patients receiving Tesofensine experienced substantially greater weight reductions compared to those on a placebo

Studies show that people who lose weight after bariatric surgery tend to keep most or all of it off, and have much lower occurrences of obesity-related conditions such as type 2 diabetes or heart disease

Optional add-ons like MIC lipotropic injections (to optimize fat burning) or Glutathione injections (for detox and immune support)

[PMID: 6263162] PubMed record related to this compound for laboratory literature review

National Center for Biotechnology Information (2023)

Get Started Today for a Healthier, More Vibrant You What Is AOD 9604